financetom
Business
financetom
/
Business
/
Zensar Tech acquires M3BI; mgmt says move strengthens AI analytics and engineering capabilities
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Zensar Tech acquires M3BI; mgmt says move strengthens AI analytics and engineering capabilities
May 17, 2021 3:35 AM

Zensar Technologies is set to acquire data engineering and advanced analytics firm M3BI. Zensar has made an upfront payment of USD 24 million and will make performance-based deferred payments of USD 9 million over 3 years. This acquisition will be completely funded by internal accruals. Ajay S Bhutoria, MD and CEO of Zensar Technologies discussed.

Share Market Live

NSE

The company has identified five strategic growth opportunities for Zensar, experienced services, advanced engineering services, data analytics, code application services and infrastructure services.

“This acquisition allows us to strengthen our existing capabilities in both advanced engineering services as well as in data engineering services,” he said.

In terms of the consideration, this is being paid for with internal resources.

“We have about USD 166 million of cash in the books and we are using a part of that towards this acquisition,” he added.

“We are operationalising the strategy now. We worked through the last three months to publish this strategy, to identify the strategic growth areas, we are operationalising that and we expect this to fire appropriately for us in the next several quarters,” he shared.

For the full interview, watch the video

(Edited by : Abhishek Jha)

First Published:May 17, 2021 12:35 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
China's Nio expects Q2 EV sales to more than double
China's Nio expects Q2 EV sales to more than double
Jun 6, 2024
SHANGHAI, June 6 (Reuters) - Chinese electric vehicle maker Nio said on Thursday that it expected its EV deliveries in the second quarter to more than double from a year ago to between 54,000 and 56,000. Revenue in the three-month period starting April would also nearly double to about $2.3 million, the company added. Nio posted a net loss of...
Remy Cointreau's shares rise as investors bet on recovery
Remy Cointreau's shares rise as investors bet on recovery
Jun 6, 2024
LONDON (Reuters) -Remy Cointreau's shares rose more than 6% on Thursday after the drinks company expressed confidence about future growth following a tough year where profits fell sharply. The maker of Remy Martin cognac and Cointreau liquor faced difficulties throughout the year in the United States and China, which make up the vast majority of cognac sales. A tough economy...
Soccer-Fan convicted of head-butting former Man Utd player Keane
Soccer-Fan convicted of head-butting former Man Utd player Keane
Jun 6, 2024
June 6 (Reuters) - A 43-year-old man was convicted on Thursday of head-butting former Manchester United captain Roy Keane following a Premier League match. Scott Law, who British media reports said was an Arsenal fan, was found guilty of assault following a trial at Highbury Magistrates' Court. The incident took place on Sept. 3 last year after Arsenal's 3-1 win...
Novartis, Roche unit and others face Italy antitrust probe over eye drug
Novartis, Roche unit and others face Italy antitrust probe over eye drug
Jun 6, 2024
ROME, June 6 (Reuters) - Italy's antitrust regulator said on Thursday it had launched an investigation into pharmaceutical companies including Novartis and Roche-controlled Genentech for having potentially restricted competition in the sale of an eye drug. Biopharma developer Samsung Bioepis, biotechs Biogen and Genentech, and Novartis, and some of their Italian, Dutch and UK units, allegedly coordinated their commercial strategies...
Copyright 2023-2025 - www.financetom.com All Rights Reserved